Latest Articles
Dostarlimab given NICE go-ahead in first-line combination treatment for endometrial cancer - Hospital Healthcare
Dostarlimab given NICE go-ahead in first-line combination treatment for endometrial cancer Hospital Healthcare
Published: March 14, 2024, 7 a.m.
GSK’s Jemperli combination recommended by NICE as first-line endometrial cancer treatment - PMLiVE
GSK’s Jemperli combination recommended by NICE as first-line endometrial cancer treatment PMLiVE
Published: March 5, 2024, 8 a.m.
Link copied to clipboard!